about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyPeptide-Based Treatment: A Promising Cancer TherapySystemically Administered, Target Organ-Specific Therapies for Regenerative MedicineUtilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliveryNanoparticle-mediated drug delivery for treating melanomaMultiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiencyBench-to-bedside translation of magnetic nanoparticlesInteractions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerPeptides as targeting probes against tumor vasculature for diagnosis and drug deliveryNew potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticlesTargeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future PerspectivesThe Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Nanomedicine in the application of uveal melanomaDose-dependent autophagic effect of titanium dioxide nanoparticles in human HaCaT cells at non-cytotoxic levelsDrug delivery nanoparticles in skin cancersQuantitative analysis of nanoparticle transport through in vitro blood-brain barrier modelsTumorHoPe: a database of tumor homing peptidesA tunable coarse-grained model for ligand-receptor interactionConstruction and application of elastin like polypeptide containing IL-4 receptor targeting peptideIncreasing Tumor Accessibility with Conjugatable Disulfide-Bridged Tumor-Penetrating Peptides for Cancer Diagnosis and Treatment.Stimuli-responsive nanomaterials for biomedical applicationsSensing the delivery and endocytosis of nanoparticles using magneto-photo-acoustic imaging.M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancerTAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance.Delivery of cancer therapeutics using nanotechnologySuperparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.Novel Methods of Enhanced Retention in and Rapid, Targeted Release from Liposomes.Advances in the field of nanooncology.Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal.Quantity and accessibility for specific targeting of receptors in tumours.Endocytosis and exocytosis of nanoparticles in mammalian cells.Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery systemUptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.New p32/gC1qR Ligands for Targeted Tumor Drug Delivery.Nanoparticle Assembly and Gelatin Binding Mediated by Triple Helical Collagen Mimetic Peptide.Cooperative tumour cell membrane targeted phototherapy.In vivo assembly of nanoparticle components to improve targeted cancer imaging.A C-14 labeled Py-Im polyamide localizes to a subcutaneous prostate cancer tumor.Etchable plasmonic nanoparticle probes to image and quantify cellular internalization.
P2860
Q26745710-B6394234-A35D-4A7D-89A8-45CD9125F9EDQ26777032-A16FBD55-F279-4BFF-B80C-FB4659E3319BQ26782082-00C3111F-F700-4480-A0A2-E8F3DAEC95F4Q26786070-B44F6084-9299-406C-AD80-C1992EC5CAB4Q26798379-50AC65BB-B87B-4783-8BA6-FED7FF9E1BABQ26827999-A1EC4A48-F59F-4280-8439-607D0DF1323BQ26850547-09586740-6A30-4D4A-AE74-A8DC8F1EC440Q27021261-1033E5A6-63E6-4E26-A88E-AD97B23E731CQ27024850-375A82F8-B268-47A7-8883-BB2ED1F61731Q27306995-E54B0F2F-1105-440A-A474-FE3AB051AE76Q28066286-8DE4221F-0F8F-49A0-AF3E-78A05085BC57Q28066801-2409732C-21B2-4CDB-96F5-C82CF04C7392Q28078448-6167A2BA-EF27-4A40-B619-4CF23457C6CAQ28079572-354B71F8-47AC-4C4D-9D53-1AF28EADEFFEQ28390233-B5864E0B-EADB-4791-A69D-F77372D44E95Q28390405-59FAC489-E570-45C2-9C8A-563F2A846A76Q28392542-217D1975-A8CC-4118-A403-4E208477A66BQ28482352-30301FEE-B41F-4174-B44B-EFD521C2D0EAQ28535097-3C2460C7-BDDA-4060-857E-3F27BDD987F0Q28536690-0E7C54C9-AEAE-433E-98BF-7745A5472FDEQ30379645-25BD458B-2B3D-4291-A842-A3F24D9C5B11Q30396768-38E0118F-08F3-443D-8FD1-663FC2F00C51Q30396796-7892D898-FFCF-4EE4-9CD9-397BFA72E9ADQ30412482-2A4E4797-AFD3-4627-B164-461852661767Q30438480-8534222D-437C-4698-8A59-896A8AA1D825Q30446963-7D841197-84CF-40EF-B647-1C58F453BCD8Q30465367-09A70E90-15C5-4F12-8841-264B37C23581Q30466993-02D7845E-D887-461E-A2F1-2AC56D01D81CQ30477604-CF485973-076C-4553-B72D-008E404B7EBAQ30577136-383C5CD8-F00D-445B-9687-6D2B24752D4FQ30580276-89A74AB2-9E56-4154-87DA-2EFB1B2CB20EQ33627669-FD00273E-A6A3-4A1C-8745-103CC9601095Q33633314-D92F9EC8-DE0F-433D-B323-7DE1D617C023Q33654083-DEEABD49-041A-44BC-A614-E7835BD952C7Q33694228-A2AE0819-1AA5-4072-A2F9-695612F0BF58Q33752601-AAE7AD7C-5DB1-41BA-B1C8-CAAFF5EC1F64Q33827119-F45DCF30-2906-4D52-99E0-5D5B878C9C71Q33952969-111C0157-3D95-4257-9C4A-2AECEAC3BB88Q34053649-0B9FCEA0-D607-426C-9839-4998A9981E4AQ34076329-AE48CB92-A212-402B-9EED-22D64EF8136F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting of drugs and nanoparticles to tumors.
@ast
Targeting of drugs and nanoparticles to tumors.
@en
type
label
Targeting of drugs and nanoparticles to tumors.
@ast
Targeting of drugs and nanoparticles to tumors.
@en
prefLabel
Targeting of drugs and nanoparticles to tumors.
@ast
Targeting of drugs and nanoparticles to tumors.
@en
P2860
P921
P356
P1476
Targeting of drugs and nanoparticles to tumors.
@en
P2093
Michael J Sailor
Sangeeta N Bhatia
P2860
P304
P356
10.1083/JCB.200910104
P407
P577
2010-03-15T00:00:00Z
2010-03-22T00:00:00Z